Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Manabe H et al. Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor. 1997 Eur. J. Pharmacol. pmid:9298930
Stewart A et al. The regulation by phosphorylation of 'priming' of phospholipase A2 activity in the neutrophil model system, differentiated HL60 cells. 1997 Br. J. Pharmacol. pmid:9298523
O'Brien JG et al. Effects of tranexamic acid and aprotinin on PAF-induced vascular permeability in normal, thrombocytopenic or neutropenic rats. 1997 Inflamm. Res. pmid:9297553
Albert DH et al. ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway rats. 1997 Inflamm. Res. pmid:9297547
Perico N et al. Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney. 1997 J. Am. Soc. Nephrol. pmid:9294830
Bozza PT et al. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. 1997 J. Exp. Med. pmid:9294145
Partrick DA et al. Lipid mediators up-regulate CD11b and prime for concordant superoxide and elastase release in human neutrophils. 1997 J Trauma pmid:9291376
Van de Weerdt ML et al. Effect of platelet-activating factor on bovine pulmonary function. 1997 Vet. Rec. pmid:9290195
Partrick DA et al. Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway. 1997 Surgery pmid:9288123
Karzai W and Reinhart K Immune modulation and sepsis. 1997 Int. J. Clin. Pract. pmid:9287265
Edwards CM et al. Effects of the co-polymer surfactant, Pluronic F-68, on platelet aggregation in human whole blood. 1997 Artif Cells Blood Substit Immobil Biotechnol pmid:9285052
Bastos da Silva M et al. Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine. 1997 Zentralbl Veterinarmed A pmid:9284631
Xie XQ et al. Differential scanning calorimetry and small angle x-ray diffraction study of the interaction of (R)-PAF, (R)-ET-18-OME and (R)-Lyso-PAF with model membranes. 1997 Life Sci. pmid:9284084
Roudebush WE et al. Evidence for the presence of the platelet-activating factor receptor in the CFW mouse preimplantation two-cell-stage embryo. 1997 Biol. Reprod. pmid:9282993
Kintner DB et al. Hyperglycemic damage to mitochondrial membranes during cerebral ischemia: amelioration by platelet-activating factor antagonist BN 50739. 1997 J. Neurochem. pmid:9282946
Rodríguez Roisin R [Platelet activating factor and bronchial asthma. Is it relevant?]. 1997 Arch. Bronconeumol. pmid:9280556
Oh SO et al. Platelet-activating factor in plasma of patients with sickle cell disease in steady state. 1997 J. Lab. Clin. Med. pmid:9280146
Kume K and Shimizu T Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor. 1997 J. Biol. Chem. pmid:9278453
Bkaily G et al. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. 1997 Mol. Cell. Biochem. pmid:9278244
Yamashita A et al. Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. 1997 J. Biochem. pmid:9276665
Ren G and Ye R [Changes in urinary excretion of platelet activating factor and its significance in patients with primary nephrotic syndrome]. 1996 Zhonghua Nei Ke Za Zhi pmid:9275622
Cheng D and Chen W Effects of ginkgolide B on isobaric hypoxic pulmonary hypertension in rats. 1996 Chin. Med. J. pmid:9275375
Chen D and Chen W Changes of distribution of platelet activating factor in the lung of rats with hypoxic pulmonary hypertension. 1996 Chin. Med. J. pmid:9275354
Klouche M et al. Endocytosis, storage, and release of IgE by human platelets: differences in patients with type I allergy and nonatopic subjects. 1997 J. Allergy Clin. Immunol. pmid:9275146
Gaumond F et al. Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells. 1997 J. Cardiovasc. Pharmacol. pmid:9269943
Grigoriadis G and Stewart AG Human monocytes maintained in culture acquire functional responsiveness to platelet-activating factor that is independent of increases in protein tyrosine phosphorylation. 1997 Clin. Exp. Pharmacol. Physiol. pmid:9269528
Shindo K et al. PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro. 1997 Biochem. Biophys. Res. Commun. pmid:9266847
Albert DH et al. Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist. 1997 Inflamm. Res. pmid:9266276
Waller KP Modulation of endotoxin-induced inflammation in the bovine teat using antagonists/inhibitors to leukotrienes, platelet activating factor and interleukin 1 beta. 1997 Vet. Immunol. Immunopathol. pmid:9261962
Tung DK et al. Leukocyte contribution to parenchymal cell death in an experimental model of inflammation. 1997 J. Leukoc. Biol. pmid:9261330
Le Gouill C et al. Structural and functional requirements for agonist-induced internalization of the human platelet-activating factor receptor. 1997 J. Biol. Chem. pmid:9261140
Ruiz-Ortega M et al. Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. 1997 J. Am. Soc. Nephrol. pmid:9259353
Palmer JS et al. A platelet activating factor antagonist attenuates the effects of testicular ischemia. 1997 J. Urol. pmid:9258168
Alonso MT et al. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis. 1997 Br. J. Pharmacol. pmid:9257915
Grimminger F et al. Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. 1997 J. Immunol. pmid:9257856
Weiss DJ and Evanson OA Detection of activated platelets and platelet-leukocyte aggregates in horses. 1997 Am. J. Vet. Res. pmid:9256963
Takahashi S et al. Role of platelet-activating factor in two-kidney, one-clip hypertension. 1997 Int. J. Urol. pmid:9256329
Teng CM et al. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man. 1997 J. Pharm. Pharmacol. pmid:9255715
Shebzukhov IuV and Mysiakin EB [Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system]. 1996 Oct-Dec Vopr. Med. Khim. pmid:9254510
Saito M et al. Association of granular exocytosis with Ca(2+)-activated K+ channels in human eosinophils. 1997 Am. J. Physiol. pmid:9252535
Sun X et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. 1997 Am. J. Physiol. pmid:9252509
Balsinde J et al. Inflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomyelin synthesis. 1997 J. Biol. Chem. pmid:9252342
Avramopoulou V et al. Synthesis of a new phosphoglycolipid with biological activity towards platelets. 1997 Int. J. Biochem. Cell Biol. pmid:9251244
Korth RM Specific binding sites for 1-O-alkyl-sn-glyceryl-3-phosphorylcholine on intact human blood neutrophils. 1997 Int. Arch. Allergy Immunol. pmid:9250592
Montrucchio G et al. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. 1997 Am. J. Pathol. pmid:9250168
Martínez-Salgado C et al. Involvement of phospholipase A2 in gentamicin-induced rat mesangial cell activation. 1997 Am. J. Physiol. pmid:9249592
Xie J et al. Dissociation of TNF-alpha from endotoxin-induced nitric oxide and acute-phase hypotension. 1997 Am. J. Physiol. pmid:9249487
Ereth MH et al. Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass? 1997 Anesth. Analg. pmid:9249097
Binisti C et al. A new phospholipase A2 inhibitor, unrelated to substrate analogues: kinetic characterization of the inhibition of secretory phospholipases A2 by PMS 832. 1997 J Lipid Mediat Cell Signal pmid:9246606
Rougier F et al. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures. 1997 J Lipid Mediat Cell Signal pmid:9246604
Travers JB et al. Identification of sn-2 acetyl glycerophosphocholines in human keratinocytes. 1997 J Lipid Mediat Cell Signal pmid:9246603
Dupuis F et al. Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. 1997 J Lipid Mediat Cell Signal pmid:9246601
Barnett CC et al. Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release. 1997 J. Surg. Res. pmid:9245567
Nakajima K et al. Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor. 1997 J. Biol. Chem. pmid:9242626
Henninger DD et al. Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. 1997 Circ. Res. pmid:9242189
Davies MG and Hagen PO Systemic inflammatory response syndrome. 1997 Br J Surg pmid:9240130
Bunting M et al. Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. 1997 J. Clin. Invest. pmid:9239403
Sengoku K et al. Involvement of protein kinases in platelet activating factor-induced acrosome reaction of human spermatozoa. 1996 Mol. Hum. Reprod. pmid:9238710
Roussev RG et al. Embryonic origin of preimplantation factor (PIF): biological activity and partial characterization. 1996 Mol. Hum. Reprod. pmid:9237230
Filep JG et al. Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. 1997 Circulation pmid:9236448
Wang X and Evans RD Effect of endotoxin and platelet-activating factor on lipid oxidation in the rat heart. 1997 J. Mol. Cell. Cardiol. pmid:9236145
Pearson JM et al. Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration. 1997 Toxicology pmid:9231696
Triggiani M et al. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. 1997 Am. J. Respir. Crit. Care Med. pmid:9230731
Díaz O et al. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation. 1997 Am. J. Respir. Crit. Care Med. pmid:9230720
Evans DJ et al. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses. 1997 Am. J. Respir. Crit. Care Med. pmid:9230719
Rhee CK et al. Effects of platelet activating factor on vascular permeability of the middle ear mucosa. 1997 Ann. Otol. Rhinol. Laryngol. pmid:9228864
Ammit AJ and O'Neill C Studies of the nature of the binding by albumin of platelet-activating factor released from cells. 1997 J. Biol. Chem. pmid:9228051
Sirois MG and Edelman ER VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. 1997 Am. J. Physiol. pmid:9227554
Stahl GL et al. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists. 1997 Am. J. Physiol. pmid:9227410
Denault S et al. Transcriptional activation of the interleukin-8 gene by platelet-activating factor in human peripheral blood monocytes. 1997 Immunology pmid:9227331
Dupuis F et al. Production and metabolism of platelet-activating factor by human bone marrow cells. 1997 Res. Immunol. pmid:9226766
Serra MF et al. Anti-allergic properties of the natural PAF antagonist yangambin. 1997 Planta Med. pmid:9225600
Lopes AH et al. Effect of platelet-activating factor on the process of cellular differentiation of Herpetomonas muscarum muscarum. 1997 Jul-Aug J. Eukaryot. Microbiol. pmid:9225446
Korotaeva AA et al. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins. 1997 Membr Cell Biol pmid:9225256
Schwartz JD et al. Lexipafant inhibits platelet activating factor enhanced neutrophil functions. 1997 J. Surg. Res. pmid:9224389
Winkler JD et al. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. 1997 Biochim. Biophys. Acta pmid:9219900
Svetlov SI et al. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide. 1997 Biochim. Biophys. Acta pmid:9219895
Balestrieri ML et al. The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells. 1997 J. Biol. Chem. pmid:9211886
Hoffman BF et al. Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes. 1997 J. Cardiovasc. Electrophysiol. pmid:9209969
Bellone G et al. Bone marrow stroma-derived prolactin is involved in basal and platelet-activating factor-stimulated in vitro erythropoiesis. 1997 Blood pmid:9207433
Zhang S et al. [Determination of platelet activating factor and platelet associated IgG in pregnancy-induced hypertension]. 1996 Zhonghua Fu Chan Ke Za Zhi pmid:9206185
Liu B et al. Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs. 1996 Chin. Med. J. pmid:9206081
Lin J et al. Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. 1997 Acta Otolaryngol. pmid:9199527
Rocha MF et al. Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes. 1997 Infect. Immun. pmid:9199444
Rodriguez-Roisin R Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. 1997 Eur. Respir. J. pmid:9192945
Sharma R et al. Direct effects of platelet-activating factor on glomerular capillary permeability. 1997 Kidney Blood Press. Res. pmid:9192907
Teixeira MM et al. Pertussis toxin shows distinct early signalling events in platelet-activating factor-, leukotriene B4-, and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo. 1997 Blood pmid:9192781
Hinterleitner TA et al. Platelet-activating factor contributes to immune cell and oxidant-mediated intestinal secretion. 1997 J. Pharmacol. Exp. Ther. pmid:9190862
Chen J and Giri SN Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages. 1997 J. Pharmacol. Exp. Ther. pmid:9190835
van der Weiden RM and Wouters JM Infertility may sometimes be associated with non-steroidal anti-inflammatory drug consumption. 1997 Br. J. Rheumatol. pmid:9189067
Lacasse C et al. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor. 1997 Inflammation pmid:9187959
Okubo Y et al. Inhibitory effects of theophylline and procaterol on eosinophil function. 1997 Intern. Med. pmid:9187566
Mathiak G et al. Platelet-activating factor (PAF) in experimental and clinical sepsis. 1997 Shock pmid:9185238
Bazan HE and Tao Y PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration. 1997 J Ocul Pharmacol Ther pmid:9185044
Ephgrave K et al. The role of platelet-activating factor in conscious, normotensive endotoxemia. 1997 J. Surg. Res. pmid:9184676
Salcedo R et al. Endogenous fibronectin of blood polymorphonuclear leukocytes: stimulus-induced secretion and proteolysis by cell surface-bound elastase. 1997 Exp. Cell Res. pmid:9184073
Stotland MA and Kerrigan CL The role of platelet-activating factor in musculocutaneous flap reperfusion injury. 1997 Plast. Reconstr. Surg. pmid:9180723
Kelefiotis D and Vakirtzi-Lemonias C Kinetics of PAF transfer, distribution and metabolism in human blood in vitro. 1997 Life Sci. pmid:9180364
Vasänge M et al. A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils. 1997 J. Pharm. Pharmacol. pmid:9178195
Lin CN et al. 2',5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. 1997 J. Pharm. Pharmacol. pmid:9178190